Proceedings of the third international molecular pathological epidemiology (MPE) meeting

Cancer Causes & Control - Tập 28 - Trang 167-176 - 2017
Peter T. Campbell1, Timothy R. Rebbeck2,3, Reiko Nishihara3,4, Andrew H. Beck5,6, Colin B. Begg7, Alexei A. Bogdanov8, Yin Cao4,9,10, Helen G. Coleman11, Gordon J. Freeman3, Yujing J. Heng5,6, Curtis Huttenhower12,13, Rafael A. Irizarry12,14, N. Sertac Kip15, Franziska Michor12,16, Daniel Nevo2,12, Ulrike Peters17,18, Amanda I. Phipps17,18, Elizabeth M. Poole2,19, Zhi Rong Qian3, John Quackenbush12,16, Harlan Robins17, Peter K. Rogan20, Martha L. Slattery21, Stephanie A. Smith-Warner2,4, Mingyang Song4,9, Tyler J. VanderWeele2, Daniel Xia22, Emily C. Zabor7, Xuehong Zhang19, Molin Wang2, Shuji Ogino2,3,23,24
1Epidemiology Research Program, American Cancer Society, Atlanta, USA
2Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
4Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, USA
5Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, USA
6Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, USA
7Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, USA
8Department of Radiology, University of Massachusetts Medical School, Worcester, USA
9Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA
10Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA
11Epidemiology and Health Services Research Group, Centre for Public Health, Queens University Belfast, Belfast, Northern Ireland
12Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, USA
13Microbial Systems and Communities, Genome Sequencing and Analysis Program, The Broad Institute, Cambridge, USA
14Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, USA
15Laboratory Medicine and Pathology, Geisinger Health System, Danville, USA
16Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
17Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
18Department of Epidemiology, School of Public Health University of Washington, Seattle, USA
19Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
20Department of Biochemistry, University of Western Ontario, London, Canada
21University of Utah School of Medicine, Salt Lake City, USA
22Department of Pathology, Brigham and Women’s Hospital, Boston, USA
23Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
24Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, USA

Tóm tắt

Molecular pathological epidemiology (MPE) is a transdisciplinary and relatively new scientific discipline that integrates theory, methods, and resources from epidemiology, pathology, biostatistics, bioinformatics, and computational biology. The underlying objective of MPE research is to better understand the etiology and progression of complex and heterogeneous human diseases with the goal of informing prevention and treatment efforts in population health and clinical medicine. Although MPE research has been commonly applied to investigating breast, lung, and colorectal cancers, its methodology can be used to study most diseases. Recent successes in MPE studies include: (1) the development of new statistical methods to address etiologic heterogeneity; (2) the enhancement of causal inference; (3) the identification of previously unknown exposure-subtype disease associations; and (4) better understanding of the role of lifestyle/behavioral factors on modifying prognosis according to disease subtype. Central challenges to MPE include the relative lack of transdisciplinary experts, educational programs, and forums to discuss issues related to the advancement of the field. To address these challenges, highlight recent successes in the field, and identify new opportunities, a series of MPE meetings have been held at the Dana–Farber Cancer Institute in Boston, MA. Herein, we share the proceedings of the Third International MPE Meeting, held in May 2016 and attended by 150 scientists from 17 countries. Special topics included integration of MPE with immunology and health disparity research. This meeting series will continue to provide an impetus to foster further transdisciplinary integration of divergent scientific fields.

Tài liệu tham khảo